Sponsors

Bruker is enabling scientists to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics.

Click here for further information!

Nautilus Biotechnology (Nasdaq: NAUT) is a life sciences company working to create a platform technology for comprehensively quantifying and unlocking the complexity of the proteome. Nautilus seeks to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. By integrating breakthrough innovations in computer science, engineering, and biochemistry we have designed a large-scale, single-molecule proteomic analysis platform capable of delivering extreme sensitivity, dynamic range, and scale for both targeted proteoform detection and broadscale discovery. By enabling an expansion of both the depth and breadth of proteomic studies, Nautilus’ technology has the potential to revolutionize how biological research is conducted, drugs are identified and developed, and human disease is treated.

To learn more about Nautilus, visit www.nautilus.bio.

Olink offers an unmatched high-multiplex technique to identify actionable biomarkers, with a strong focus on the human plasma proteome. Using minimal sample volume we provide quantifiable results with high-throughput, exceptional sensitivity and specificity, with coverage across a broad dynamic range. Our mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology. We are committed to develop our offering and are continuously expanding our protein coverage for a growing number of biological processes and pathways. Olink is well-established in Europe (HQ Uppsala, Sweden) and the USA (HQ Boston, MA), with a rapidly developing presence across Asia. We also work with a growing number of core labs around the world offering analysis and support to an expanding global customer base. For more information visit www.olink.com 

Get in touch with us: Contact us — Olink®

Alamar Biosciences is powering precision proteomics with automated, high throughput solutions for ultra-high sensitivity protein analysis across a range of multiplex levels from biofluid samples.  Our proprietary NULISA™ Chemistry utilizes a novel sequential capture and release method reducing background signal and increasing sensitivity and dynamic range compared with standard approaches.  With both qPCR and NGS readouts, NULISA enables both focused analysis of validated biomarkers to highly multiplexed profiling of hundreds to ultimately thousands of proteins. The NULISAseq™ Inflammation Panel 250 contains 250+ important markers of immune response enabling comprehensive protein analysis of immune and inflammatory diseases. The NULISAseq™ CNS Disease Panel 120 provides ultra-sensitive and robust analysis of 120+ proteins to support protein biomarker discovery and validation studies and includes biomarkers such as pTau-217, GFAP and alpha-synuclein.  The NULISA immunoassays run on the innovative ARGO™ HT System, allowing for a fully automated workflow with <30 minutes total hands-on time and single-plex results in <8 hours or comprehensive multiplex analysis in <16 hours.

Click here to find out more!

At Biognosys, we believe that deep proteome insights hold the key to breakthrough discoveries that transform science for better lives. With our versatile portfolio of next-generation proteomics solutions, including the TrueDiscovery®, TrueTarget®, and TrueSignature® research service platforms, our flagship software Spectronaut®, and the PQ500™ kit, we make the proteome actionable to empower research, drug development, and clinical decision-making. Our solutions provide a multi-dimensional view of protein expression, function, and structure in all biological species and sample types. Our unique, patented technologies utilize high-resolution mass spectrometry to quantify thousands of proteins with industry-leading precision, depth, and throughput. Through our strategic partnership with Bruker (Nasdaq: BRKR), we make proteomics globally accessible. For more information, visit biognosys.com.

SCIEX delivers innovative tools that help proteomics researchers quickly find meaningful answers with confidence. With the new ZenoTOF 7600+ system, recently named Analytical Scientist’s #1 innovation of 2021, and its revolutionary Zeno trap and electron-activated dissociation, researchers can now routinely identify, quantify and characterize critical low-abundance proteins and their post-translational modifications.

Click here to find out more!

Bioinformatics Solutions Inc. (BSI) is an AI-driven biotechnology company that is committed to advancing research by providing innovative proteomics solutions with machine learning and ground-breaking algorithms integrated into the latest mass spectrometry technology. BSI is best known in the research community for the development of the mass spectrometry-based proteomics software, PEAKS. The mission of the company is to facilitate drug discovery and advance the frontier of biological research through AI-driven commercial software and professional contract research organization services.

Learn more: www.bioinfor.com

Covaris provides comprehensive, integrated workflows for proteomics, genomics, and beyond. Covaris solutions can help you improve your sample preparation performance. They easily integrate into manual or automated workflows and support a wide variety of sample types, batch sizes, and input volumes. By reducing touchpoints, turnaround time, and repeat downstream analysis, Covaris sample prep solutions can lower your total workflow costs. Learn how Covaris can help take you further, faster.

Click here to find out more!

Evosep aims to improve quality of life and patient care by radically innovating protein based clinical diagnostics. Making sample preparation and separation before MS analysis 10 times faster and 100 times more robust will enable truly large cohort studies for biomarker validation and provide the foundation for precision medicine.

Click here to find out more!

Quantum-Si, The Protein Sequencing Company™, has a mission to make protein sequencing and analysis available to all scientists so that every lab, everywhere can better understand the role of proteins in cell biology and disease and use this knowledge to transform the world we live in. QSI brings the groundbreaking power of single-molecule proteomics with the first-to-market Next-Generation Protein Sequencer™, Platinum® and a straightforward workflow, space-saving benchtop instrument, and the power to precisely detect protein variants and modifications. Call or email us: 1–866-688-7374 | sales@quantum-si.com | support@quantum-si.com.

Click here for more information!

Seer develops innovative solutions that act as a gateway to the proteome. Our products are designed to accelerate the pace of proteomics by removing the technological barriers that stand between you and the proteomics you want to do. The Proteograph platform enables unbiased, deep, rapid, large-scale proteomics studies – the kind needed to advance our understanding of biology, health, and disease. It is now possible to accurately survey and analyze the full diversity of proteins across individuals, over time. Our goal is to empower the scientific community with tools for exceptional proteomics outcomes.

Click here to find out more!

SomaLogic, a part of Standard BioTools, is catalyzing drug research and development and biomarker identification as a global leader in proteomics technology. With a single 55 microliter plasma or serum sample, SomaLogic can run 11,000 protein measurements, covering half the human  proteome. For more than 20 years we’ve supported pharmaceutical companies, and academic and contract research organizations who rely on our protein detection and analysis technologies to fuel drug, disease, and treatment discoveries in such areas as oncology, diabetes, and cardiovascular, liver, and metabolic diseases. Find out more at www.somalogic.com and follow @somalogic on LinkedIn.

Tecan (www.tecan.com) improves people’s lives and health by empowering customers to scale healthcare innovation globally from life science to the clinic. Tecan is a pioneer and global leader in laboratory automation. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments, components and medical devices that are then distributed by partner companies. Founded in Switzerland in 1980, the company has more than 3,500 employees, with manufacturing, research and development sites in Europe, North America and Asia, and maintains a sales and service network in over 70 countries. In 2022, Tecan generated sales of CHF 1,144 million (USD 1,192 million; EUR 1,144 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).

Click here to find out more!